Division of General Internal Medicine and Health Services Research, Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles.
Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
JAMA Intern Med. 2023 Jul 1;183(7):696-704. doi: 10.1001/jamainternmed.2023.1253.
The best approach to identify younger postmenopausal women for osteoporosis screening is uncertain. The Fracture Risk Assessment Tool (FRAX), which includes self-identified racial and ethnic information, and the Osteoporosis Self-assessment Tool (OST), which does not, are risk assessment tools recommended by US Preventive Services Task Force guidelines to identify candidates for bone mineral density (BMD) testing in this age group.
To compare the ability of FRAX vs OST to discriminate between younger postmenopausal women who do and do not experience incident fracture during a 10-year follow-up in the 4 racial and ethnic groups specified by FRAX.
DESIGN, SETTING, AND PARTICIPANTS: This cohort study of Women's Health Initiative participants included 67 169 women (baseline age range, 50-64 years) with 10 years of follow-up for major osteoporotic fracture (MOF; including hip, clinical spine, forearm, and shoulder fracture) at 40 US clinical centers. Data were collected from October 1993 to December 2008 and analyzed between May 11, 2022, and February 23, 2023.
Incident MOF and BMD (in a subset of 4607 women) were assessed. The area under the receiver operating characteristic curve (AUC) for FRAX (without BMD information) and OST was calculated within each racial and ethnic category.
Among the 67 169 participants, mean (SD) age at baseline was 57.8 (4.1) years. A total of 1486 (2.2%) self-identified as Asian, 5927 (8.8%) as Black, 2545 (3.8%) as Hispanic, and 57 211 (85.2%) as White. During follow-up, 5594 women experienced MOF. For discrimination of MOF, AUC values for FRAX were 0.65 (95% CI, 0.58-0.71) for Asian, 0.55 (95% CI, 0.52-0.59) for Black, 0.61 (95% CI, 0.56-0.65) for Hispanic, and 0.59 (95% CI, 0.58-0.59) for White women. The AUC values for OST were 0.62 (95% CI, 0.56-0.69) for Asian, 0.53 (95% CI, 0.50-0.57) for Black, 0.58 (95% CI, 0.54-0.62) for Hispanic, and 0.55 (95% CI, 0.54-0.56) for White women. For discrimination of femoral neck osteoporosis, AUC values were excellent for OST (range, 0.79 [95% CI, 0.65-0.93] to 0.85 [95% CI, 0.74-0.96]), higher for OST than FRAX (range, 0.72 [95% CI, 0.68-0.75] to 0.74 [95% CI, 0.60-0.88]), and similar in each of the 4 racial and ethnic groups.
These findings suggest that within each racial and ethnic category, the US FRAX and OST have suboptimal performance in discrimination of MOF in younger postmenopausal women. In contrast, for identifying osteoporosis, OST was excellent. The US version of FRAX should not be routinely used to make screening decisions in younger postmenopausal women. Future investigations should improve existing tools or create new approaches to osteoporosis risk assessment for this age group.
确定骨质疏松症筛查的年轻绝经后女性的最佳方法尚不确定。骨折风险评估工具(FRAX),包括自我识别的种族和民族信息,和骨质疏松症自我评估工具(OST),不包括,是美国预防服务工作组指南推荐的风险评估工具,用于确定该年龄段骨密度(BMD)检测的候选者。
比较 FRAX 与 OST 在识别 4 个种族和民族中 10 年随访期间发生骨折事件的年轻绝经后女性的能力。
设计、地点和参与者:本研究为妇女健康倡议参与者的队列研究,包括 67169 名女性(基线年龄范围为 50-64 岁),40 个美国临床中心进行了 10 年的主要骨质疏松性骨折(MOF;包括髋部、临床脊柱、前臂和肩部骨折)随访。数据于 1993 年 10 月至 2008 年 12 月收集,并于 2022 年 5 月 11 日至 2023 年 2 月 23 日进行分析。
评估了 MOF 和 BMD(在 4607 名女性的亚组中)。在每个种族和民族类别内计算了 FRAX(无 BMD 信息)和 OST 的接收者操作特征曲线(ROC)下面积(AUC)。
在 67169 名参与者中,基线时的平均(SD)年龄为 57.8(4.1)岁。共有 1486 名(2.2%)自认为是亚洲人,5927 名(8.8%)是黑人,2545 名(3.8%)是西班牙裔,57211 名(85.2%)是白人。随访期间,5594 名女性发生 MOF。对于 MOF 的鉴别,FRAX 的 AUC 值为亚洲人 0.65(95%CI,0.58-0.71),黑人 0.55(95%CI,0.52-0.59),西班牙裔 0.61(95%CI,0.56-0.65),白种人 0.59(95%CI,0.58-0.59)。OST 的 AUC 值为亚洲人 0.62(95%CI,0.56-0.69),黑人 0.53(95%CI,0.50-0.57),西班牙裔 0.58(95%CI,0.54-0.62),白种人 0.55(95%CI,0.54-0.56)。对于股骨颈骨质疏松症的鉴别,OST 的 AUC 值非常好(范围为 0.79[95%CI,0.65-0.93]至 0.85[95%CI,0.74-0.96]),高于 FRAX(范围为 0.72[95%CI,0.68-0.75]至 0.74[95%CI,0.60-0.88]),在 4 个种族和民族中相似。
这些发现表明,在每个种族和民族类别中,美国 FRAX 和 OST 在识别年轻绝经后女性的 MOF 方面表现不佳。相比之下,OST 对识别骨质疏松症非常有效。美国版的 FRAX 不应该常规用于年轻绝经后女性的筛查决策。未来的研究应该改进现有的工具或为该年龄段的骨质疏松症风险评估创造新的方法。